Apyx Medical
APYX
49 hedge funds and large institutions have $17.5M invested in Apyx Medical in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 7 closing their positions.
48,200% more call options, than puts
Call options by funds: $483K | Put options by funds: $1K
0.71% less ownership
Funds ownership: 38.5% → 37.79% (-0.71%)
3% less capital invested
Capital invested by funds: $18.1M → $17.5M (-$596K)
4% less funds holding
Funds holding: 51 → 49 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$457K |
| 2 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
+$221K |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$183K |
| 4 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
+$111K |
| 5 |
RA
Royce & Associates
New York
|
+$89.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$497K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$207K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$157K |
| 4 |
Squarepoint
New York
|
-$104K |
| 5 |
Millennium Management
New York
|
-$102K |
APYX Hedge Fund Activity: Q2 2024 in Review
49 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2024, worth a combined $17.5M — down 3.3% from $18.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of APYX and 5 opened new positions — a net loss of 2 holders — while 19 trimmed existing stakes and 13 added.
The largest buyer was Private Advisor Group, opening a new position worth an estimated $457K. The largest seller was Archon Capital Management, cutting an estimated $497K.
- 49 institutional investors held Apyx Medical (APYX) as of Q2 2024, down from 51 in Q1 2024.
- Funds reported $17.5M of Apyx Medical stock for Q2 2024, down 3.3% quarter-over-quarter.
- 5 funds opened new Apyx Medical positions in Q2 2024 and 7 closed out, a net change of -2 holders.
- The largest Apyx Medical buyer in Q2 2024 was Private Advisor Group, an estimated $457K added.
- The largest Apyx Medical seller in Q2 2024 was Archon Capital Management, an estimated $497K sold.
Based on aggregated 13F filings for Q2 2024.